drugset / Trial / NCT00003403

GPX-100 in Treating Patients With Solid Tumors

NCT00003403 ↗

Phase 1 Completed Gem Pharmaceuticals
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of GPX-100 in treating patients who have solid tumors.

Timeline

Start
1999-08
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject 13-deoxydoxorubicin Small molecule — Intravenous